<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00808028</url>
  </required_header>
  <id_info>
    <org_study_id>6108A1-2001</org_study_id>
    <secondary_id>B1971005</secondary_id>
    <secondary_id>2008-007789-51</secondary_id>
    <nct_id>NCT00808028</nct_id>
  </id_info>
  <brief_title>A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents</brief_title>
  <official_title>A Randomized, Single-blind, Placebo-controlled, Phase 2 Trial Of The Safety, Immunogenicity, And Tolerability Of Meningococcal Serogroup B (Mnb) Rlp2086 Vaccine At Doses Of 60 Mug, 120 Mug, And 200 Mug In Healthy Adolescents Aged 11 To 18 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and immunogenicity of an investigational
      meningococcal B rLP2086 vaccine in adolescents aged 11 to 18 years old.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 2</measure>
    <time_frame>Before vaccination 1 up to 1 month after vaccination 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 3</measure>
    <time_frame>Before vaccination 1 up to 1 month after vaccination 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Atleast One Adverse Event (AE): Stage 1</measure>
    <time_frame>Vaccination 1 upto 1 Month after vaccination 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Atleast One Adverse Event (AE): Stage 2</measure>
    <time_frame>6 month after vaccination 3 up to 48 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Level Greater Than or Equal To (&gt;=) Prespecified Titer Level</measure>
    <time_frame>1 month before vaccination 1, 1 month after vaccination 2, 3</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Immunogloblulin G (IgG) Measured by Geometric Mean Titer (GMT) for Sub Family A and Sub Family B</measure>
    <time_frame>Before Vaccination 1, 1 month after vaccination 2, 1 month after vaccination 3</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">538</enrollment>
  <condition>Meningitis, Meningococcal</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dose level 1 rLP2086 vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dose level 2 rLP2086 vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dose level 3 rLP2086 vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline (placebo)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>meningococcal B rLP2086 vaccine.</intervention_name>
    <description>vaccine, 0.5 mL, 0 - 2 - 6 to 9 months</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>meningococcal B rLP2086 vaccine.</intervention_name>
    <description>vaccine, 0.5 mL, 0 - 2 - 6 to 9 months</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>meningococcal B rLP2086 vaccine.</intervention_name>
    <description>vaccine, 0.5 mL, 0 - 2 - 6 to 9 months</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal saline (placebo)</intervention_name>
    <description>vaccine, 0.5 mL, 0 - 2 - 6 to 9 months</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female subjects between the ages of &gt;=11 and &lt;=18 years at the time of
             enrollment.

          -  Negative urine pregnancy test for all female subjects.

          -  Parent/legal guardian or subject under supervision of the parent/legal guardian must
             be able to complete all relevant study procedures during study participation.

        Exclusion Criteria:

          -  History of any invasive meningococcal disease.

          -  A previous anaphylactic or severe vaccine-associated adverse reaction.

          -  Any clinically significant chronic disease.

          -  A known or suspected disease of the immune system or those receiving immunosuppressive
             therapy, including systemic corticosteroids. Topical, inhaled or intra-articular
             corticosteroids are allowed.

          -  Participation in another investigational study in the 1-month (30-day) period before
             study visit 1 and during the conduct of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queensland Paediatric Infectious Diseases (QPID) Laboratory</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Paediatrics, Women's &amp; Children's Hospital</name>
      <address>
        <city>North Adelaide</city>
        <state>South Australia</state>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Carlton</city>
        <state>Victoria</state>
        <zip>3053</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Clinical Research Facility, Vaccine Trials Group (VTG),</name>
      <address>
        <city>Subiaco</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZOZ w Debicy, Poradnia Chorob Zakaznych</name>
      <address>
        <city>Debica</city>
        <zip>39-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP ZOZ Krakowski Szpital Specjalistyczny im. Jana Pawla II w Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie,</name>
      <address>
        <city>Krakow</city>
        <zip>31-503</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Salmed</name>
      <address>
        <city>Leczna</city>
        <zip>21-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Specjalistyczny Szpital im. dr Wl. Bieganskiego w Lodzi</name>
      <address>
        <city>Lodz</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego</name>
      <address>
        <city>Lodz</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPZOZ w Lubartowie, Oddzial Pediatryczny, ul. Cicha 14</name>
      <address>
        <city>Lubartow</city>
        <zip>21-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eskulap Sp. z o. o., ul. Weteranow 46</name>
      <address>
        <city>Lublin</city>
        <zip>20-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP ZOZ, Poradnia Dziecieca w Grucie</name>
      <address>
        <city>Melno</city>
        <zip>86-330</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Pratyka Lekarza Rodzinnego Alina Grocka-Wlazlak</name>
      <address>
        <city>Oborniki Slaskie</city>
        <zip>55-120</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny ZOZ nad Matka i Dzieckiem w Poznaniu Oddzial Obserwacyjno-Zakazny A</name>
      <address>
        <city>Poznan</city>
        <zip>61-734</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZLA Michalkowice, Jarosz i Partnerzy</name>
      <address>
        <city>Siemianowice Slaskie</city>
        <zip>41-03</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Nasz Lekarz Praktyka Grupowa Lekarzy Rodzinnych z Przychodnia</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Dzieciecy Szpital im. Swietej Jadwigi Slaskiej</name>
      <address>
        <city>Trzebnica</city>
        <zip>55-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Pediatrii i Chorob Infekcyjnych</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-345</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 1</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-345</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>La Coruna</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital U. de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Xeral-Cies de Vigo</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Virgen del Mar</name>
      <address>
        <city>Almeria</city>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Cataluna</name>
      <address>
        <city>Barcelona</city>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital U. 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Nazaret</name>
      <address>
        <city>Valencia</city>
        <zip>46024</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6108A1-2001&amp;StudyName=A%20Study%20Evaluating%20Safety%20And%20Immunogenicity%20Of%20Meningococcal%20B%20Rlp2086%20Vaccine%20In%20Adolescents</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2008</study_first_submitted>
  <study_first_submitted_qc>December 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2008</study_first_posted>
  <results_first_submitted>March 27, 2015</results_first_submitted>
  <results_first_submitted_qc>March 27, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 14, 2015</results_first_posted>
  <last_update_submitted>March 27, 2015</last_update_submitted>
  <last_update_submitted_qc>March 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Meningitis, Meningococcal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
        <group group_id="P2">
          <title>rLP2086 60 Microgram (mcg)</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
        </group>
        <group group_id="P3">
          <title>rLP2086 120 mcg</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
        <group group_id="P4">
          <title>rLP2086 200 mcg</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Stage 1 (6 Months)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="121"/>
                <participants group_id="P2" count="22">Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2</participants>
                <participants group_id="P3" count="198"/>
                <participants group_id="P4" count="198"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
                <participants group_id="P2" count="21">Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2</participants>
                <participants group_id="P3" count="191"/>
                <participants group_id="P4" count="183"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Parent/legal guardian request</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Stage 2 (Followed up to 48 Months )</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="80">Out of 511 completed participants in Stage 1, 89 did not enter Stage 2</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="170"/>
                <participants group_id="P4" count="151"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="69">Out of 511 completed participants in Stage 1, 89 did not enter Stage 2</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="141"/>
                <participants group_id="P4" count="128"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to return</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Parent's or guardian request</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The stage 1 intent-to-treat (ITT) population included all randomized participants who received at least 1 vaccination and have at least 1 valid and determinate assay result from blood samples drawn during stage 1.</population>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
        <group group_id="B2">
          <title>rLP2086 60 mcg</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1.</description>
        </group>
        <group group_id="B3">
          <title>rLP2086 120 mcg</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
        <group group_id="B4">
          <title>rLP2086 200 mcg</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="121"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="198"/>
            <count group_id="B4" value="198"/>
            <count group_id="B5" value="539"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.8" spread="2.05"/>
                    <measurement group_id="B2" value="13.3" spread="1.84"/>
                    <measurement group_id="B3" value="14.3" spread="2.11"/>
                    <measurement group_id="B4" value="14.0" spread="2.01"/>
                    <measurement group_id="B5" value="14.0" spread="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="113"/>
                    <measurement group_id="B4" value="103"/>
                    <measurement group_id="B5" value="288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="85"/>
                    <measurement group_id="B4" value="95"/>
                    <measurement group_id="B5" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 2</title>
        <time_frame>Before vaccination 1 up to 1 month after vaccination 2</time_frame>
        <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control-Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 60 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 120 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O4">
            <title>rLP2086 200 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 2</title>
          <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subfamily A Strain A05 (N= 80, 18, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="88.9"/>
                    <measurement group_id="O3" value="83.5"/>
                    <measurement group_id="O4" value="87.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subfamily B Strain B02 (N= 84, 21, 121, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="71.4"/>
                    <measurement group_id="O3" value="59.5"/>
                    <measurement group_id="O4" value="59.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0007</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0392</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0225</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0244</p_value>
            <method>Binomial Distribution</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 3</title>
        <time_frame>Before vaccination 1 up to 1 month after vaccination 3</time_frame>
        <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control-Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 60 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 120 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O4">
            <title>rLP2086 200 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With at Least 4-fold Rise in Recombinant Lipoprotein 2086 (rLP2086) Specific Serum Bactericidal Assay Using Human Complement (hSBA) Titer: Before Vaccination 1 up to 1 Month After Vaccination 3</title>
          <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subfamily A Strain A05 (N= 73, 19, 111,100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5"/>
                    <measurement group_id="O2" value="89.5"/>
                    <measurement group_id="O3" value="92.8"/>
                    <measurement group_id="O4" value="94.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subfamily B Strain B02 (N= 79, 21, 112,105)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="81.0"/>
                    <measurement group_id="O3" value="86.6"/>
                    <measurement group_id="O4" value="84.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0004</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strain A05: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.9999</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0036</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Strain B02: Response rate was compared with whether greater than (&gt;) 50% of participants had fold rise &gt;=4 using right one-sided exact test based on binomial distribution and the corresponding p-values were calculated. p-value &lt; 0.025 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Atleast One Adverse Event (AE): Stage 1</title>
        <time_frame>Vaccination 1 upto 1 Month after vaccination 3</time_frame>
        <population>Safety population included participants who received at least 1 dose of study vaccine.</population>
        <group_list>
          <group group_id="O1">
            <title>Control-Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 60 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 120 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O4">
            <title>rLP2086 200 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Atleast One Adverse Event (AE): Stage 1</title>
          <population>Safety population included participants who received at least 1 dose of study vaccine.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="198"/>
                <count group_id="O4" value="195"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Stage 1: Vaccination phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.6"/>
                    <measurement group_id="O2" value="81.8"/>
                    <measurement group_id="O3" value="38.9"/>
                    <measurement group_id="O4" value="47.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 1: 6-month follow up phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1"/>
                    <measurement group_id="O2" value="18.2"/>
                    <measurement group_id="O3" value="1.5"/>
                    <measurement group_id="O4" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Atleast One Adverse Event (AE): Stage 2</title>
        <time_frame>6 month after vaccination 3 up to 48 months</time_frame>
        <population>Safety population included participants who received at least 1 dose of study vaccine.</population>
        <group_list>
          <group group_id="O1">
            <title>Control- Stage 2</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 120 mcg- Stage 2</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 200 mcg- Stage 2</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Atleast One Adverse Event (AE): Stage 2</title>
          <population>Safety population included participants who received at least 1 dose of study vaccine.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="170"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="4.1"/>
                    <measurement group_id="O3" value="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Level Greater Than or Equal To (&gt;=) Prespecified Titer Level</title>
        <time_frame>1 month before vaccination 1, 1 month after vaccination 2, 3</time_frame>
        <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control-Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 60 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 120 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O4">
            <title>rLP2086 200 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Level Greater Than or Equal To (&gt;=) Prespecified Titer Level</title>
          <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A04 Predose 1;1:32 (N= 64, 15, 90, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="10.0"/>
                    <measurement group_id="O4" value="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A04 Predose 1;1:64 (N= 64, 15, 90, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="7.8"/>
                    <measurement group_id="O4" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A04 Predose 1;1:128 (N= 64, 15, 90, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.1"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A04 1-month postdose 2;1:32 (N= 69, 21, 115, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="95.2"/>
                    <measurement group_id="O3" value="98.3"/>
                    <measurement group_id="O4" value="91.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A04 1-month postdose 2;1:64 (N= 69, 21, 115, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                    <measurement group_id="O2" value="85.7"/>
                    <measurement group_id="O3" value="82.6"/>
                    <measurement group_id="O4" value="72.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A04 1-month postdose 2;1:128 (N= 69, 21, 115, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                    <measurement group_id="O2" value="52.4"/>
                    <measurement group_id="O3" value="44.3"/>
                    <measurement group_id="O4" value="42.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 Predose 1;1:16 (N= 81, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="9.0"/>
                    <measurement group_id="O4" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 Predose 1;1:32 (N= 81, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="5.7"/>
                    <measurement group_id="O4" value="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 Predose 1;1:64 (N= 81, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 Predose 1;1:128 (N= 81, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 2;1:16 (N= 83, 18, 118, 110)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2"/>
                    <measurement group_id="O2" value="88.9"/>
                    <measurement group_id="O3" value="89.0"/>
                    <measurement group_id="O4" value="90.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 2;1:32 (N= 83, 18, 118, 110)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="88.9"/>
                    <measurement group_id="O3" value="85.6"/>
                    <measurement group_id="O4" value="81.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 2;1:64 (N= 83, 18, 118, 110)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="83.3"/>
                    <measurement group_id="O3" value="59.3"/>
                    <measurement group_id="O4" value="64.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 2;1:128 (N= 83, 18, 118, 110)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="33.3"/>
                    <measurement group_id="O3" value="28.0"/>
                    <measurement group_id="O4" value="40.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 3;1:16 (N= 76, 20, 114, 104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.8"/>
                    <measurement group_id="O2" value="90.0"/>
                    <measurement group_id="O3" value="96.5"/>
                    <measurement group_id="O4" value="96.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 3;1:32 (N= 76, 20, 114, 104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9"/>
                    <measurement group_id="O2" value="90.0"/>
                    <measurement group_id="O3" value="94.7"/>
                    <measurement group_id="O4" value="95.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 3;1:64 (N= 76, 20, 114, 104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9"/>
                    <measurement group_id="O2" value="85.0"/>
                    <measurement group_id="O3" value="89.5"/>
                    <measurement group_id="O4" value="87.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A05 1-month postdose 3;1:128 (N= 76, 20, 114, 104)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="40.0"/>
                    <measurement group_id="O3" value="68.4"/>
                    <measurement group_id="O4" value="60.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 Predose 1;1:16 (N= 80, 21, 119, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="7.6"/>
                    <measurement group_id="O4" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 Predose 1;1:32 (N= 80, 21, 119, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5"/>
                    <measurement group_id="O2" value="4.8"/>
                    <measurement group_id="O3" value="5.0"/>
                    <measurement group_id="O4" value="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 Predose 1;1:64 (N= 80, 21, 119, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 Predose 1;1:128 (N= 80, 21, 119, 115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 2;1:16 (N= 81, 20, 117, 107)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3"/>
                    <measurement group_id="O2" value="85.0"/>
                    <measurement group_id="O3" value="94.9"/>
                    <measurement group_id="O4" value="96.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 2;1:32 (N= 81, 20, 117, 107)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1"/>
                    <measurement group_id="O2" value="85.0"/>
                    <measurement group_id="O3" value="90.6"/>
                    <measurement group_id="O4" value="88.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 2;1:64 (N= 81, 20, 117, 107)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.9"/>
                    <measurement group_id="O2" value="80.0"/>
                    <measurement group_id="O3" value="80.3"/>
                    <measurement group_id="O4" value="71.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 2;1:128 (N= 81, 20, 117, 107)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="45.0"/>
                    <measurement group_id="O3" value="39.3"/>
                    <measurement group_id="O4" value="45.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 3 ;1:16 (N= 78, 21, 114, 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5"/>
                    <measurement group_id="O2" value="95.2"/>
                    <measurement group_id="O3" value="97.4"/>
                    <measurement group_id="O4" value="95.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 3 ;1:32 (N= 78, 21, 114, 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0"/>
                    <measurement group_id="O2" value="85.7"/>
                    <measurement group_id="O3" value="93.9"/>
                    <measurement group_id="O4" value="93.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 3 ;1:64 (n= 78, 21, 114, 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8"/>
                    <measurement group_id="O2" value="71.4"/>
                    <measurement group_id="O3" value="91.2"/>
                    <measurement group_id="O4" value="84.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A56 1-month postdose 3;1:128 (N= 78, 21, 114, 112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6"/>
                    <measurement group_id="O2" value="61.9"/>
                    <measurement group_id="O3" value="74.6"/>
                    <measurement group_id="O4" value="67.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 postdose 1;1:16 (N= 84, 22, 124, 118)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.6"/>
                    <measurement group_id="O4" value="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 postdose 1;1:32 (N= 84, 22, 124, 118)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 postdose 1;1:64 (N= 84, 22, 124, 118)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 postdose 1;1:128 (N= 84, 22, 124, 118)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 2 ;1:16 (N= 84, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="76.2"/>
                    <measurement group_id="O3" value="68.9"/>
                    <measurement group_id="O4" value="65.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 2 ;1:32 (N= 84, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="57.1"/>
                    <measurement group_id="O3" value="45.9"/>
                    <measurement group_id="O4" value="48.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 2 ;1:64 (N= 84, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="42.9"/>
                    <measurement group_id="O3" value="25.4"/>
                    <measurement group_id="O4" value="21.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 2;1:128 (N= 84, 21, 122, 114)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="14.3"/>
                    <measurement group_id="O3" value="7.4"/>
                    <measurement group_id="O4" value="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 3 ;1:16 (N= 79, 21, 113, 105)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8"/>
                    <measurement group_id="O2" value="85.7"/>
                    <measurement group_id="O3" value="90.3"/>
                    <measurement group_id="O4" value="85.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 3 ;1:32 (N= 79, 21, 113, 105)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="81.0"/>
                    <measurement group_id="O3" value="78.8"/>
                    <measurement group_id="O4" value="79.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 3 ;1:64 (N= 79, 21, 113, 105)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="57.1"/>
                    <measurement group_id="O3" value="52.2"/>
                    <measurement group_id="O4" value="60.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B02 1-month postdose 3;1:128 (N= 79, 21, 113, 105)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="42.9"/>
                    <measurement group_id="O3" value="19.5"/>
                    <measurement group_id="O4" value="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 Predose 1;1:16 (N= 83, 22, 118, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 Predose 1;1:32 (N= 83, 22, 118, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 Predose 1;1:64 (N= 83, 22, 118, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 Predose 1;1:128 (N= 83, 22, 118, 117)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 2;1:16 (N= 84, 19, 102, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="21.1"/>
                    <measurement group_id="O3" value="32.4"/>
                    <measurement group_id="O4" value="30.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 2;1:32 (N= 84, 19, 102, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="21.1"/>
                    <measurement group_id="O3" value="30.4"/>
                    <measurement group_id="O4" value="28.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 2;1:64 (N= 84, 19, 102, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="5.3"/>
                    <measurement group_id="O3" value="22.5"/>
                    <measurement group_id="O4" value="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 2;1:128 (N= 84, 19, 102, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="10.8"/>
                    <measurement group_id="O4" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 3;1:16 (N= 68, 15, 86, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9"/>
                    <measurement group_id="O2" value="53.3"/>
                    <measurement group_id="O3" value="75.6"/>
                    <measurement group_id="O4" value="67.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 3;1:32 (N= 68, 15, 86, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4"/>
                    <measurement group_id="O2" value="53.3"/>
                    <measurement group_id="O3" value="75.6"/>
                    <measurement group_id="O4" value="66.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 3;1:64 (N= 68, 15, 86, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                    <measurement group_id="O2" value="46.7"/>
                    <measurement group_id="O3" value="60.5"/>
                    <measurement group_id="O4" value="58.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B03 1-month postdose 3;1:128 (N= 68, 15, 86, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="26.7"/>
                    <measurement group_id="O3" value="27.9"/>
                    <measurement group_id="O4" value="24.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 Predose 1 ;1:8 (N= 81, 22, 120, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="3.3"/>
                    <measurement group_id="O4" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 Predose 1 ;1:16 (N= 81, 22, 120, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.7"/>
                    <measurement group_id="O4" value="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 Predose 1 ;1:32 (N= 81, 22, 120, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 Predose 1 ;1:64 (N= 81, 22, 120, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 Predose 1 ;1:128 (N= 81, 22, 120, 116)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 2;1:8 (n= 81, 21, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="61.9"/>
                    <measurement group_id="O3" value="68.7"/>
                    <measurement group_id="O4" value="70.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 2;1:16 (N= 81, 21, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="61.9"/>
                    <measurement group_id="O3" value="60.9"/>
                    <measurement group_id="O4" value="64.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 2;1:32 (N= 81, 21, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="47.6"/>
                    <measurement group_id="O3" value="43.5"/>
                    <measurement group_id="O4" value="42.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 2;1:64 (N= 81, 21, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="23.8"/>
                    <measurement group_id="O3" value="22.6"/>
                    <measurement group_id="O4" value="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 2;1:128 (N= 81, 21, 115, 106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="6.1"/>
                    <measurement group_id="O4" value="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 3;1:8 (N= 83, 21, 115, 111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8"/>
                    <measurement group_id="O2" value="76.2"/>
                    <measurement group_id="O3" value="88.7"/>
                    <measurement group_id="O4" value="86.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 3; 1:16 (N= 83, 21, 115, 111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="76.2"/>
                    <measurement group_id="O3" value="86.1"/>
                    <measurement group_id="O4" value="85.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 3;1:32 (N= 83, 21, 115, 111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="76.2"/>
                    <measurement group_id="O3" value="80.9"/>
                    <measurement group_id="O4" value="80.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 3;1:64 (N= 83, 21, 115, 111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="47.6"/>
                    <measurement group_id="O3" value="53.9"/>
                    <measurement group_id="O4" value="61.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B44 1-month postdose 3;1:128 (N= 83, 21, 115, 111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="9.5"/>
                    <measurement group_id="O3" value="22.6"/>
                    <measurement group_id="O4" value="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Immunogloblulin G (IgG) Measured by Geometric Mean Titer (GMT) for Sub Family A and Sub Family B</title>
        <time_frame>Before Vaccination 1, 1 month after vaccination 2, 1 month after vaccination 3</time_frame>
        <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
        <group_list>
          <group group_id="O1">
            <title>Control-Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O2">
            <title>rLP2086 60 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
          </group>
          <group group_id="O3">
            <title>rLP2086 120 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
          <group group_id="O4">
            <title>rLP2086 200 mcg- Stage 1</title>
            <description>Given on a 0, 2-, 6-month schedule in Stage 1 and follow-up to 48 months in Stage 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Immunogloblulin G (IgG) Measured by Geometric Mean Titer (GMT) for Sub Family A and Sub Family B</title>
          <population>mITT population included all randomized participants who received at least 1 vaccination and had at least 1 valid and determinate assay result. Here, 'N' signifies those participants who were evaluable for this measure during specified time period.</population>
          <units>Titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subfamily(Sf) A Predose 1(N=106,22,156,173)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" lower_limit="2.6" upper_limit="5.1"/>
                    <measurement group_id="O2" value="4.3" lower_limit="1.6" upper_limit="11.7"/>
                    <measurement group_id="O3" value="7.2" lower_limit="5.3" upper_limit="9.8"/>
                    <measurement group_id="O4" value="4.9" lower_limit="3.8" upper_limit="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sf A 1-month postdose 2(N=104, 22,168,166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" lower_limit="3.5" upper_limit="6.9"/>
                    <measurement group_id="O2" value="984.6" lower_limit="663.8" upper_limit="1460.4"/>
                    <measurement group_id="O3" value="1115.5" lower_limit="962.8" upper_limit="1292.5"/>
                    <measurement group_id="O4" value="1285.8" lower_limit="1082.3" upper_limit="1527.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sf A 1-month postdose 3(N=98,20, 158,148)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" lower_limit="3.9" upper_limit="8.5"/>
                    <measurement group_id="O2" value="3120.3" lower_limit="1959.5" upper_limit="4968.8"/>
                    <measurement group_id="O3" value="2289.5" lower_limit="1967.0" upper_limit="2664.9"/>
                    <measurement group_id="O4" value="2342.6" lower_limit="2003.9" upper_limit="2738.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sf B Predose 1(N= 106,22,155,172)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2.6" upper_limit="4.6"/>
                    <measurement group_id="O2" value="4.2" lower_limit="1.4" upper_limit="12.7"/>
                    <measurement group_id="O3" value="5.4" lower_limit="4.1" upper_limit="7.2"/>
                    <measurement group_id="O4" value="3.9" lower_limit="3.0" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sf B 1-month postdose 2(N=104, 22,168,166)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="2.7" upper_limit="5.0"/>
                    <measurement group_id="O2" value="405.8" lower_limit="298.7" upper_limit="551.4"/>
                    <measurement group_id="O3" value="816.5" lower_limit="701.0" upper_limit="951.1"/>
                    <measurement group_id="O4" value="852.0" lower_limit="729.1" upper_limit="995.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sf B 1-month postdose 3(N=98,20,158,148)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" lower_limit="2.9" upper_limit="5.7"/>
                    <measurement group_id="O2" value="3264.2" lower_limit="2502.3" upper_limit="4258.1"/>
                    <measurement group_id="O3" value="2246.8" lower_limit="1988.1" upper_limit="2539.2"/>
                    <measurement group_id="O4" value="2553.3" lower_limit="2256.0" upper_limit="2889.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AE reported from Vaccination 1 upto 48 months after vaccincation 3 and SAE reported from Vaccination 1 upto 48 months after vaccincation 3</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control- Stage 1</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
        </group>
        <group group_id="E2">
          <title>rLP2086 60 mcg- Stage 1</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
        </group>
        <group group_id="E3">
          <title>rLP2086 120 mcg- Stage 1</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
        </group>
        <group group_id="E4">
          <title>rLP2086 200 mcg- Stage 1</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1</description>
        </group>
        <group group_id="E5">
          <title>Control-Stage 1 Follow-up</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1</description>
        </group>
        <group group_id="E6">
          <title>rLP2086 60 mcg- Stage 1 Follow up</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1</description>
        </group>
        <group group_id="E7">
          <title>rLP2086 120 mcg- Stage 1 Follow up</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1</description>
        </group>
        <group group_id="E8">
          <title>rLP2086 200 mcg- Stage 1 Follow up</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1</description>
        </group>
        <group group_id="E9">
          <title>Control-Stage 2</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1 and further up to 48 months in Stage 2</description>
        </group>
        <group group_id="E10">
          <title>rLP2086 120 mcg- Stage 2</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1 and further up to 48 months in Stage 2</description>
        </group>
        <group group_id="E11">
          <title>rLP2086 200 mcg- Stage 2</title>
          <description>Given on a 0, 2-, 6-month schedule in Stage 1, were then followed up to 6 months in Stage 1 and further up to 48 months in Stage 2</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 17.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Eczema impetiginous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tonsillitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Mononucleosis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>CNS germinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Cerebellar tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 17.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="75" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="91" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Factor V Leiden mutation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Eyelid cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tooth impacted</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site pallor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Vaccination site pallor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to animal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Allergy to chemicals</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Mumps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pertussis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pulpitis dental</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Whiplash injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Chemical burn of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Foreign body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Post concussion syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood iron decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Muscle contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Torticollis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Burning sensation mucosal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Penile discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Asthma exercise induced</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Hangnail</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="121"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="198"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="195"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="170"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="151"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

